By Colin Kellaher
Shares of iCAD took flight in premarket trading Wednesday after the medical-technology company agreed to be acquired by diagnostic-imaging-services provider RadNet in a stock swap valued at about $103 million.
RadNet on Tuesday said it will issue 0.0677 shares, worth about $3.59 based on Tuesday's closing price of $53.08 for the Los Angeles company, for each share of iCAD.
The deal, slated to close in the second or third quarter, represents a roughly 86% premium to Tuesday's closing price of $1.93 for iCAD, based in Nashua, N.H.
ICAD shares were recently up 73% at $3.34 in premarket trading.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 16, 2025 06:14 ET (10:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。